Agreed wholeheartedly DB
Don't want to know a thing about what the company is planning.
Certainly don't want to know what they are doing.
Never release one iota of information of strategies or tactics.
It is a dog eat dog, kill or be killed Pharma drug and device world out there!
Never, ever tell anyone your business . . . .
If they receive a regulatory clearance, tell us, only if it does not impede corporate growth in any way. If they sign a deal with a pharma chain, CVS, Walgreens or the independent corner pharmacy, don't tell me until it is good for BIEL.
The future now, with so many positive things going on is only about reporting sales and profits, when regulatory requirements say the company must. Until then, stay silent. I could list 10 things I know or firmly believe to be true (that is to say confirmed by at least two solid and reliable sources) that would blow people out of their chairs here, but I won't because it will serve no good purposes other than whetting appetites of curiosity and letting competitors know what BIEL may or may not be doing.
I have complete faith now in Andrew Whelan, who, incidentally, got us here, and the rest of his team and I am 100% confident as to the future stock price of BIEL.
Because of the upside, I am sooooo patient and sleep soooo well, knowing this company is like a Tsunami. FDA cleared, NHS Tariff inclusion launching April 1? And at least 15 other positive things going on, that I have personally verified through extensive DD, I need nothing else.
ActiPatch, patented, efficacious, safe pain management, FDA cleared, NHS covered in the UK in 16 days . . . . you know when
